GlassScriptPhysician profile
Allison D Clements
NPI 1669402715
$2,985.97
in general payments reported to CMS, 2019-2025
31 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $544 · 2022: $402 · 2023: $671 · 2024: $928 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,990 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.70 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $904.13 | 2021-2025 | |
| Amgen INC. | $252.20 | 2021-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $192.37 | 2021-2023 | Emgality, Jardiance, Trulicity |
| Lexicon Pharmaceuticals, INC. | $154.03 | 2023-2024 | Inpefa |
| Novo Nordisk INC | $129.22 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Idorsia Pharmaceuticals US INC | $124.52 | 2022-2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $120.36 | 2022-2023 | |
| Impulse Dynamics (USA) INC. | $93.41 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $92.07 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $91.09 | 2021-2024 | Verquvo |
| Glaxosmithkline, LLC. | $83.64 | 2021-2023 | Trelegy Ellipta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.46 | 2024 | Lifevest |
| Currax Pharmaceuticals LLC | $77.87 | 2022-2023 | Nexletol, Nexlizet, Contrave |
| Axsome Therapeutics, INC. | $66.68 | 2025 | Auvelity |
| Atricure, INC. | $58.28 | 2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.78 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $45.51 | 2024 | |
| Sanofi-Aventis U.S. LLC | $41.02 | 2021-2023 | |
| Irhythm Technologies, INC. | $38.35 | 2024 | Zio Monitor, Zio Xt Patch |
| Kiniksa Pharmaceuticals International, Plc | $38.25 | 2024 | Arcalyst |
| Corcept Therapeutics | $35.72 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $31.71 | 2022-2024 | Farxiga |
| Dexcom, INC. | $31.52 | 2023 | Dexcom G6 Transmitter |
| Abiomed | $22.66 | 2025 | |
| Organon LLC | $20.38 | 2023 | Nexplanon |
| Abbott Laboratories | $19.47 | 2021 | |
| Amarin Pharma, INC. | $19.02 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.52 | 2022 | |
| Phathom Pharmaceuticals, INC. | $16.20 | 2025 | Voquezna |
| Paratek Pharmaceuticals, INC. | $15.06 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.47 | 2024 | Artis Icono Floor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Clements listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.